IMR Press / EJGO / Volume 38 / Issue 3 / DOI: 10.12892/ejgo3423.2017

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research
MPV, NLR, and platelet count: new hematologic markers in diagnosis of malignant ovarian tumor
Show Less
1 Inonu University Turgut Ozal Medical Center Obstetrics and Gynecology Department, Malatya, Turkey
2 Inonu University Turgut Ozal Medical Pathology Department, Department, Malatya, Turkey
3 Inonu University Turgut Ozal Medical Radiation Oncology Department, Malatya, Turkey
Eur. J. Gynaecol. Oncol. 2017, 38(3), 346–349;
Published: 10 June 2017

Objective: Evaluation of mean platelet volume (MPV), neutrophil to lymphocyte ratio (NLR), and platelet count in the detection of malignant and benign ovarian tumors. Material and Methods: Sixty-six patients admitted to the present clinic over three years were included in the study. Patients diagnosed with ovarian cancer were grouped into the areas of epithelial and granulosa cell tumor diagnosis. The values were compared to patients with benign cystic structure. Patients’ preoperative hematologic parameters and their values four weeks postoperatively were analyzed. Statistical analyses were performed with SPSS software. Results: MPV, NLR, and platelet count were observed at a higher rate as statistically significant in patients diagnosed with malignant ovarian cancer, compared to those with benign adnexal mass. Conclusion: The hematological parameters such as MPV, NLR, and platelet count in the detection of malignant ovarian tumors have been evaluated as useful new markers.
Ovarian tumors
Back to top